India · Delayed Price · Currency is INR Hester Biosciences Statistics
Total Valuation
NSE:HESTERBIO has a market cap or net worth of INR 17.67 billion. The enterprise value is 19.63 billion.
| Market Cap | 17.67B |
| Enterprise Value | 19.63B |
Important Dates
The next estimated earnings date is Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | Aug 6, 2025 |
Share Statistics
| Current Share Class | 8.51M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -3.20% |
| Shares Change (QoQ) | +2.56% |
| Owned by Insiders (%) | 63.75% |
| Owned by Institutions (%) | 0.28% |
| Float | 2.66M |
Valuation Ratios
The trailing PE ratio is 31.75.
| PE Ratio | 31.75 |
| Forward PE | n/a |
| PS Ratio | 5.31 |
| PB Ratio | 4.80 |
| P/TBV Ratio | 5.04 |
| P/FCF Ratio | 38.15 |
| P/OCF Ratio | 27.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.10, with an EV/FCF ratio of 42.38.
| EV / Earnings | 35.27 |
| EV / Sales | 5.90 |
| EV / EBITDA | 21.10 |
| EV / EBIT | 26.47 |
| EV / FCF | 42.38 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.37 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 2.25 |
| Debt / FCF | 4.21 |
| Interest Coverage | 6.20 |
Financial Efficiency
Return on equity (ROE) is 16.56% and return on invested capital (ROIC) is 9.23%.
| Return on Equity (ROE) | 16.56% |
| Return on Assets (ROA) | 6.36% |
| Return on Invested Capital (ROIC) | 9.23% |
| Return on Capital Employed (ROCE) | 12.90% |
| Weighted Average Cost of Capital (WACC) | 6.74% |
| Revenue Per Employee | 5.92M |
| Profits Per Employee | 990,018 |
| Employee Count | 562 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 1.15 |
Taxes
In the past 12 months, NSE:HESTERBIO has paid 183.52 million in taxes.
| Income Tax | 183.52M |
| Effective Tax Rate | 24.20% |
Stock Price Statistics
The stock price has increased by +15.03% in the last 52 weeks. The beta is 0.50, so NSE:HESTERBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +15.03% |
| 50-Day Moving Average | 1,767.69 |
| 200-Day Moving Average | 1,675.54 |
| Relative Strength Index (RSI) | 67.12 |
| Average Volume (20 Days) | 15,515 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HESTERBIO had revenue of INR 3.33 billion and earned 556.39 million in profits. Earnings per share was 67.57.
| Revenue | 3.33B |
| Gross Profit | 2.51B |
| Operating Income | 677.77M |
| Pretax Income | 758.36M |
| Net Income | 556.39M |
| EBITDA | 866.58M |
| EBIT | 677.77M |
| Earnings Per Share (EPS) | 67.57 |
Balance Sheet
The company has 65.38 million in cash and 1.95 billion in debt, with a net cash position of -1.88 billion.
| Cash & Cash Equivalents | 65.38M |
| Total Debt | 1.95B |
| Net Cash | -1.88B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.68B |
| Book Value Per Share | 423.46 |
| Working Capital | 560.84M |
Cash Flow
In the last 12 months, operating cash flow was 641.41 million and capital expenditures -178.28 million, giving a free cash flow of 463.13 million.
| Operating Cash Flow | 641.41M |
| Capital Expenditures | -178.28M |
| Depreciation & Amortization | 188.81M |
| Net Borrowing | -361.27M |
| Free Cash Flow | 463.13M |
| FCF Per Share | n/a |
Margins
Gross margin is 75.36%, with operating and profit margins of 20.38% and 16.73%.
| Gross Margin | 75.36% |
| Operating Margin | 20.38% |
| Pretax Margin | 22.80% |
| Profit Margin | 16.73% |
| EBITDA Margin | 26.05% |
| EBIT Margin | 20.38% |
| FCF Margin | 13.92% |
Dividends & Yields
This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 0.34%.
| Dividend Per Share | 7.00 |
| Dividend Yield | 0.34% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 10.83% |
| Buyback Yield | 3.20% |
| Shareholder Yield | 3.55% |
| Earnings Yield | 3.15% |
| FCF Yield | 2.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |